Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer

Details for Australian Patent Application No. 2006220405 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors End, David William; Venet, Marc Gaston; Angibaud, Patrick Rene

Agent Shelston IP

Pub. Number AU-B-2006220405

Parent 2001263962

Filing date 20 September 2006

Wipo publication date 12 October 2006

Acceptance publication date 21 May 2009

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

5 October 2006 Complete Application Filed

12 October 2006 Application Open to Public Inspection

  Published as AU-B-2006220405

21 May 2009 Application Accepted

  Published as AU-B-2006220405

17 September 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006220406-Radio frequency identification method and system of distributing products

2006220404-Stabilized protein compositions